Can there be a role for the purpose of cannabidiol inside psychiatry? Marketplace L Biol Psychiatry. 2017:1–16.20.Habib W, Artul S.
Professional medical cannabis meant for dealing with fibromyalgia. L Clin Rheumatol. 2018;14:14. Moth miller RJ, Burns RE.
Is certainly cannabis just right just for joint? Clin Exp Rheumatol. 2017;35 Suppl 107(5):59–67. Kim PS, Fishman MA. Cannabis regarding problems together with headaches: primer.
Curr Discomfort Trouble Rep. 2017;21(4):19. Reddy DS. The utility with cannabidiol for the relief refractory epilepsy.
Clin Pharmacol Ther. 2017;101(2):182–4. O’Connell BK, Semblance Ve had, Devinsky O. Cannabinoids within treatment-resistant epilepsy: a review.
Epilepsy Behav E&lifier;B. 2017;70(Pt B):341–8. Landa 50, Jurica L, Sliva L, Pechackova L, Demlova R. Professional medical cannabis found in managing cancer malignancy agony and then spastic visit environments and even methods with illegal drug shipment in surgical practice.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018;19:19. Lintzeris In, Driels N, Elias D, Arnold JC, McGregor IS, Allsop DJ. Medicative cannabis in Projects, 2016: a Cannabis mainly because Medicine Study (CAMS-16).
Mediterranean sea N Aust. 2018;209(5):211–6. Lisboa SF, Gomes FV, Terzian AL, Aguiar DC, Moreira FA, Resstel LB, et al. All the endocannabinoid procedure plus anxiety.
Vitam Horm. 2017;103:193–279. Ruehle Erinarians, Rey AA, Remmers F, Lutz B. Any endocannabinoid device throughout panic, anxiety reminiscence not to mention habituation.
J Psychopharmacol (Oxford, UK). 2012;26(1):23–39. Russo EB, Burnett The, Lounge S, Parker KK. Agonistic premises associated with cannabidiol on 5-HT1a receptors.
Neurochem Res. 2005;30(8):1037–43. Howlett AC, Blume LC, Dalton GD. CB(1) cannabinoid receptors along with ones own affiliated proteins.
Curr Mediterranean Chem. 2010;17(14):1382–93. Pertwee RG. A numerous CB1 along with CB2 sensory receptor pharmacology from two grow cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and additionally delta9-tetrahydrocannabivarin.
Br L Pharmacol. 2008;153(2):199–215. Bhattacharyya Ohydrates, Morrison PD, Fusar-Poli L, Martin-Santos M, Borgwardt Utes, Winton-Brown To, et al. Antipode results of delta-9-tetrahydrocannabinol and additionally cannabidiol concerning person brain function not to mention psychopathology.
Neuropsychopharmacology. 2010;35(3):764–74. Dalton WS, Martz S, Lemberger D, Rodda BE, Forney RB. Have an impact on connected with cannabidiol in delta-9-tetrahydrocannabinol effects.
Clin Pharmacol Ther. 1976;19(3):300–9. Englund A, Morrison PD, Nottage M, Hague Chemical, Kane L, Bonaccorso Ohydrates, et al. Cannabidiol suppresses THC-elicited paranoiac symptoms and additionally hippocampal-dependent ram impairment.
J Psychopharmacol. 2013;27(1):19–27. Karniol IG, Shirakawa That i, Kasinski D, Pfeferman Some sort of, Carlini EA. Cannabidiol disturbs the consequences of delta 9 – tetrahydrocannabinol around man.
Eur J Pharmacol. 1974;28(1):172–7. Kedzior KK, Laeber LT. An organization amongst anxiety disorders and then cannabis employ and cannabis make use of ailments around the reccommended population–a meta-analysis involved with 31 studies.
BMC Psychiatry. 2014;14:136. Feingold G, Rehm L, Component They would, Redler A fabulous, Lev-Ran S. Specialized medical as well as sensible successes about cannabis benefit from between people who have anxiety disorders: any 3-year population-based longitudinal study.